PMC:7408073 / 82527-82922
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T460 | 21-27 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T461 | 357-360 | Body_part | denotes | V-2 | http://purl.org/sig/ont/fma/fma13443|http://purl.org/sig/ont/fma/fma68615 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2887 | 55-63 | Species | denotes | patients | Tax:9606 |
| 2888 | 70-80 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 2889 | 195-203 | Species | denotes | patients | Tax:9606 |
| 2898 | 46-54 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 2899 | 186-194 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T462 | 46-54 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T463 | 70-78 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T464 | 70-74 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T465 | 186-194 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T466 | 349-353 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T994 | 21-27 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T995 | 114-117 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T996 | 135-136 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T997 | 245-248 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T63956 | 354-356 | Chemical | denotes | Co | http://purl.obolibrary.org/obo/CHEBI_27638 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T406 | 0-395 | Sentence | denotes | Actually, the use of plasma from convalescent COVID-19 patients or of SARS-CoV-2-specific neutralizing antibodies has been shown to be a promising option for the treatment of critically COVID-19 patients [32,33,34,35,36,37,172,173]; however, it has some limitations that might be overcome by vaccine strategies or by the production of specific anti SARS-Co-V-2 therapeutic monoclonal antibodies. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32708755-32065055-20678966 | 205-207 | 32065055 | denotes | 32 |
| 32708755-32366817-20678967 | 208-210 | 32366817 | denotes | 33 |
| 32708755-32404477-20678968 | 211-213 | 32404477 | denotes | 34 |
| 32708755-32253318-20678969 | 217-219 | 32253318 | denotes | 36 |
| 32708755-32243945-20678970 | 220-222 | 32243945 | denotes | 37 |
| 32708755-32505227-20678971 | 223-226 | 32505227 | denotes | 172 |